130
Views
20
CrossRef citations to date
0
Altmetric
PHARMACEUTICAL ANALYSIS

Spectrophotometric Determination of Ceftazidime in Pharmaceutical Preparations Using Neocuproin as a Complexing Agent

&
Pages 2143-2152 | Received 27 Mar 2008, Accepted 01 May 2008, Published online: 15 Aug 2008
 

Abstract

A simple and reproducible spectrophotometric method for the assay of ceftazidime with neocuproin-copper(II) reagent has been developed. The procedure is based on the drug in an acidic medium, subsequent formation of yellow ternary complex in citrate buffer solution (pH 4.2), and measurement at 454 nm. Beer's law is obeyed in the range 15.0–40.0 µg mL−1 with correlation coefficient r 2 = 0.9995. The procedure holds good accuracy and precision when applied to the analysis of ceftazidime in powder for injection with good recovery percent ranging from 100.17±1.0 without interference from additives.

This work was supported by PADC-FCF-UNESP (Araraquara, Brazil), CNPq (Brasília, Brazil), and FAPESP (São Paulo, Brazil). We thank Ariston Química e Farmacêutica Ltda (São Paulo, Brazil) for providing the ceftazidime reference and the pharmaceutical preparations. We would like to thank Maria de Fátima Rodrigues Lopes for technical support.

Notes

*10 ml volumetric flask.

a Mean of three replicates analysis.

a Mean of three replicates analyses.

s = standard deviation.

RSD% = percentual relative standard deviation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.